Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

Nature

Volumn 476, Issue 7360, 2011, Pages 298-303

  Morin, Ryan D ^a   Mendez Lago, Maria ^a   Mungall, Andrew J ^a   Goya, Rodrigo ^a   Mungall, Karen L ^a   Corbett, Richard D ^a   Johnson, Nathalie A ^a   Severson, Tesa M ^a   Chiu, Readman ^a   Field, Matthew ^a   Jackman, Shaun ^a   Krzywinski, Martin ^a   Scott, David W ^a   Trinh, Diane L ^a   Tamura Wells, Jessica ^a   Li, Sa ^a   Firme, Marlo R ^a   Rogic, Sanja ^a   Griffith, Malachi ^a   Chan, Susanna ^a   Yakovenko, Oleksandr ^a   Meyer, Irmtraud M ^b   Zhao, Eric Y ^a   Smailus, Duane ^a   Moksa, Michelle ^a   Chittaranjan, Suganthi ^a   Rimsza, Lisa ^c   Brooks Wilson, Angela ^a,d   Spinelli, John J ^a,e   Ben Neriah, Susana ^a   Meissner, Barbara ^a   Woolcock, Bruce ^a   Boyle, Merrill ^a   McDonald, Helen ^a   Tam, Angela ^a   Zhao, Yongjun ^a   Delaney, Allen ^a   Zeng, Thomas ^a   Tse, Kane ^a   Butterfield, Yaron ^a   Birol, Inana ^a   Holt, Rob ^a   Schein, Jacqueline ^a   Horsman, Douglas E ^a   Moore, Richard ^a   Jones, Steven J M ^a   Connors, Joseph M ^a   Hirst, Martin ^a   Gascoyne, Randy D ^a,e   Marra, Marco A ^a,e   more..

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b Centre for High throughput Biology   (Canada)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d SIMON FRASER UNIVERSITY   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DNA; E1A ASSOCIATED P300 PROTEIN; HISTONE; HISTONE METHYLTRANSFERASE; RNA;

CALCIUM; CYTOLOGY; ENZYME ACTIVITY; MOLECULAR ANALYSIS; MUTATION; PROTEIN; TUMOR;

ARTICLE; BIOLOGY; CANCER GENETICS; CHEMICAL MODIFICATION; CHROMATIN; FOLLICULAR LYMPHOMA; GENE DISRUPTION; GENE MUTATION; HUMAN; LARGE CELL LYMPHOMA; LYMPHANGIOGENESIS; PRIORITY JOURNAL; RNA SEQUENCE; SOMATIC MUTATION;

CHROMATIN; DNA-BINDING PROTEINS; GENOME, HUMAN; HISTONE ACETYLTRANSFERASES; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; LOSS OF HETEROZYGOSITY; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MADS DOMAIN PROTEINS; MUTATION; MYOGENIC REGULATORY FACTORS; NEOPLASM PROTEINS;

EID: 80052029516     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature10351     Document Type: Article

References (50)

1. Anderson, J. R., Armitage, J. O., Weisenburger, D. D., Non-Hodgkin's Lymphoma Classification Project. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Ann. Oncol. 9, 717-720 (1998). (Pubitemid 28394156)
2. Lenz, G. & Staudt, L. M. Aggressive lymphomas. N. Engl. J. Med. 362, 1417-1429 (2010).
3. Horsman, D. E. et al. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes. Br. J. Haematol. 120, 424-433 (2003). (Pubitemid 36241498)
4. Iqbal, J. et al. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am. J. Pathol. 165, 159-166 (2004). (Pubitemid 38821823)
5. Lenz, G. et al. Molecular subtypes of diffuse large B-cell lymphomaarise by distinct genetic pathways. Proc. Natl Acad. Sci. USA 105, 13520-13525 (2008).
6. Pasqualucci, L. et al. Inactivation of the PRDM1/BLIMP1 gene in diffuse largeBcell lymphoma. J. Exp. Med. 203, 311-317 (2006). (Pubitemid 43290840)
7. Kato, M. et al. Frequent inactivation of A20 in B-cell lymphomas. Nature 459, 712-716 (2009).
8. Compagno, M. et al. Mutations of multiple genes cause deregulation of NF-kB in diffuse large B-cell lymphoma. Nature 459, 717-721 (2009).
9. Davis, R. E. et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463, 88-92 (2010).
10. Ngo, V. N. et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 470, 115-119 (2011).
11. Mardis, E. R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058-1066 (2009).
12. Shah, S. P. et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461, 809-813 (2009).
13. Morin, R. D. et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nature Genet. 42, 181-185 (2010).
14. Futreal, P. A. et al.A census of humancancer genes. Nature Rev. Cancer 4, 177-183 (2004).
15. Pasqualucci, L. et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471, 189-195 (2011).
16. Yusuf, I., Zhu, X., Kharas, M. G., Chen, J. & Fruman, D. A. Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Blood 104, 784-787 (2004). (Pubitemid 38970574)
17. Saito, M. et al. BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc. Natl Acad. Sci. USA 106, 11294-11299 (2009).
18. Lenz, G. et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676-1679 (2008). (Pubitemid 351432507)
19. Greenman, C., Wooster, R., Futreal, P. A., Stratton, M. R. & Easton, D. F. Statistical analysis of pathogenicity of somatic mutations in cancer. Genetics 173, 2187-2198 (2006). (Pubitemid 44285695)
20. Cheung, K. J. et al. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res. 70, 9166-9174 (2010).
21. Du, M. Q. et al. BCL10 genemutation in lymphoma. Blood 95, 3885-3890 (2000).
22. Kreutz, B., Hajicek, N., Yau, D. M., Nakamura, S. & Kozasa, T. Distinct regions of Ga13 participate in its regulatory interactions with RGS homology domaincontaining RhoGEFs. Cell. Signal. 19, 1681-1689 (2007). (Pubitemid 46935425)
23. Bhattacharyya, R. & Wedegaertner, P. Ga13 requires palmitoylation for plasma membrane localization, Rho-dependent signaling, and promotion of p115-RhoGEF membrane binding. J. Biol. Chem. 275, 14992-14999 (2000). (Pubitemid 30337217)
24. Manganello, J. M.,Huang, J., Kozasa, T., Voyno-Yasenetskaya, T. A.&Le Breton, G. C. Protein kinase A-mediated phosphorylation of the Ga13 switch I region alters the Gabc13-G protein-coupled receptor complex and inhibits Rho activation. J. Biol. Chem. 278, 124-130 (2003). (Pubitemid 36043553)
25. Brunet, A. et al. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol. Cell. Biol. 21, 952-965 (2001). (Pubitemid 32104742)
26. Tai, D. J. C., Su, C.-C., Ma, Y.-L. & Lee, E. H. Y. SGK1 phosphorylation of IkB kinase a and p300 Up-regulates NF-kB activity and increases N-methyl-D-aspartate receptor NR2A and NR2B expression. J. Biol. Chem. 284, 4073-4089 (2009).
27. Mo, J. et al. Serum-and glucocorticoid-inducible kinase 1 (SGK1) controls Notch1 signaling by downregulation of protein stability through Fbw7 ubiquitin ligase. J. Cell Sci. 124, 100-112 (2011).
28. Young, K. H. et al. Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. Blood 112, 3088-3098 (2008).
29. Shilatifard, A. Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation. Curr. Opin. Cell Biol. 20, 341-348 (2008).
30. Milne, T. et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell 10, 1107-1117 (2002). (Pubitemid 35453828)
31. Krumlauf, R. Hox genes in vertebrate development. Cell 78, 191-201 (1994). (Pubitemid 24241088)
32. Canaani, E. et al. ALL-1//MLL1, a homologue of Drosophila TRITHORAX, modifies chromatin and is directly involved in infant acute leukaemia. Br. J. Cancer 90, 756-760 (2004). (Pubitemid 38406582)
33. Wang, P. et al. Global analysis of H3K4 methylation defines MLL family member targets and points to a role forMLL1-mediatedH3K4methylation in the regulation of transcriptional initiation by RNA polymerase II. Mol. Cell. Biol. 29, 6074-6085 (2009).
34. Issaeva, I. et al. Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Mol. Cell. Biol. 27, 1889-1903 (2007).
35. Pleasance, E. D. et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463, 184-190 (2010).
36. Dalgliesh, G. L. et al. Systematic sequencing of renal carcinomareveals inactivation of histone modifying genes. Nature 463, 360-363 (2010).
37. Parsons, D. W. et al. The genetic landscape of the childhood cancer medulloblastoma. Science 331, 435-439 (2011).
38. Iqbal, J. et al. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia 21, 2332-2343 (2007). (Pubitemid 350011706)
39. Pasini, D. et al. Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res. (2010).
40. Giordano, A. & Avantaggiati, M. p300 and CBP: partners for life and death. J. Cell. Physiol. 181, 218-230 (1999). (Pubitemid 29463637)
41. Han, A., He, J., Wu, Y., Liu, J. O. & Chen, L. Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2. J. Mol. Biol. 345, 91-102 (2005). (Pubitemid 39572827)
42. Youn, H. & Liu, J. Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity 13, 85-94 (2000).
43. Yap, D. B. et al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 117, 2451-2459 (2011).
44. Sneeringer, C. J. et al. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas. Proc. Natl Acad. Sci. USA 107, 20980-20985 (2010).
45. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
46. Goya, R. et al. SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors. Bioinformatics 26, 730-736 (2010).
47. Robertson, G. et al. De novo assembly and analysis of RNA-seq data. Nature Methods 7, 909-912 (2010).
48. Mortazavi, A., Williams, B. A., Mccue, K., Schaeffer, L. & Wold, B. Mapping and quantifyingmammalian transcriptomesbyRNA-Seq. NatureMethods 5, 621-628 (2008).
49. Wright, G. et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc. Natl Acad. Sci. USA 100, 9991-9996 (2003). (Pubitemid 37087056)
50. He, J. et al. Structure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assembly. Nucleic Acids Res. (2011).